Coalition endorses GS1 systems for unique device identifiers
This article was originally published in The Silver Sheet
The Healthcare Supply Chain Standards Coalition has endorsed the global organizational and product identifier systems of the international standards organization GS1. Because the coalition's oversight committee includes FDA, Abbott, Johnson & Johnson, Cardinal Health and the American Hospital Association, the endorsement likely means that FDA's independent system for unique device identifiers (UDIs) will rely on GS1's systems. The creation of a UDI system was one of the top recommendations made by CDRH's Postmarket Transformation Leadership Team in last year's report, and was mandated by the recent FDA Amendments Act ("The Silver Sheet" October 2007)
You may also be interested in...
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.